​In celebration of World Health Day, the American Cancer Society (ACS) Journals ​have spotlighted an outstanding​ publication authored by Dr. Malik Juweid and colleagues, titled "Beyond Fluorodeoxyglucose: Molecular Imaging of Cancer in Precision Medicine," published in CA: A Cancer Journal for Clinicians.

This landmark review explores advanced molecular imaging approaches in oncology, highlighting radiotracers beyond the widely used FDG, such as PSMA ligands, somatostatin receptor agents, FAPI, and CXCR4-targeted imaging. The paper emphasizes the pivotal role of molecular imaging in advancing precision medicine and improving cancer diagnosis, staging, and treatment monitoring.

​

“I am honored to have my research published in CA: A Cancer Journal for Clinicians,” said Prof Juweid. “This publication provides a platform to share our synthesis and critical evaluation of the most important research findings in nuclear cancer molecular imaging with a global audience of clinicians and researchers, helping to identify new research opportunities and ultimately contributing to the advancement of cancer care. I'm thankful for the support of the University of Jordan and my research team.”

This publication further solidifies the University of Jordan’s position as a leading institution for medical research and innovation in the region.​

Read fulltext: https://doi.org/10.3322/caac.70007​

​​​